Home › NDC Lookup › RxCUI directory › RxCUI 310274

Famotidine 8 MG/ML Oral Suspension — RxCUI 310274

RxNorm drug concept · Semantic clinical drug
RxCUI 310274 Semantic clinical drug · SCD ● Current RxNorm concept 21 FDA products 23 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310274
Official nameFamotidine 8 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asfamotidine 40 MG per 5 ML Oral Suspension; famotidine 40 MG in 5 mL Oral Suspension
FDA products mapped21
Package NDCs mapped23
Reported Medicaid activity (SDUD)913,418 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Famotidine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Famotidine injection is specifically for people in the hospital who can't swallow pills right now — maybe because of surgery, a procedure, or another medical reason. It delivers th...
  • Why am I getting famotidine through an IV instead of just taking a pill?
  • Because it goes straight into your vein, it works fast. The maximum acid-reducing effect kicks in within about 30 minutes of the infusion, and that effect can last 10 to 12 hours....
  • How quickly will famotidine injection start working?
📖 Read our full Famotidine Injection guide →

🕸️ Concept Web — How Famotidine 8 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Famotidine 8 MG/ML Oral Suspension RxCUI 310274

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Famotidine 4278
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Famotidine Oral Suspension 372139
    • Famotidine Oral Liquid Product 1159020
    • Famotidine Oral Product 1159021
    • Oral Suspension 316969
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Famotidine 8 MG/ML 315922

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Famotidine 8 MG/ML SCDC · 315922
  • Famotidine Oral Suspension SCDF · 372139
  • Famotidine Oral Liquid Product SCDG · 1159020
  • Famotidine Oral Product SCDG · 1159021

📦 FDA Products & Package NDCs

21 products · 23 package NDCs
23 package NDCs map to RxCUI 310274 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00527-5190-80 55 mL in 1 BOTTLE (0527-5190-80) Famotidine Lannett Company, Inc. 2025-06-02
00832-6045-10 100 mL in 1 BOTTLE (0832-6045-10) Famotidine Upsher-Smith Laboratories, LLC 2023-10-27
00832-6045-15 150 mL in 1 BOTTLE (0832-6045-15) Famotidine Upsher-Smith Laboratories, LLC 2023-10-27
00832-6045-50 50 mL in 1 BOTTLE (0832-6045-50) Famotidine Upsher-Smith Laboratories, LLC 2023-07-11
27241-0249-49 50 mL in 1 BOTTLE (27241-249-49) Famotidine Ajanta Pharma USA Inc. 2022-04-25
31722-0063-31 50 mL in 1 BOTTLE (31722-063-31) FAMOTIDINE Camber Pharmaceuticals, Inc. 2023-08-17
42571-0433-45 50 mL in 1 BOTTLE (42571-433-45) FAMOTIDINE Micro Labs Limited 2023-12-01
43386-0500-11 50 mL in 1 BOTTLE (43386-500-11) Famotidine Lupin Pharmaceuticals,Inc. 2012-12-17
43598-0572-11 50 mL in 1 BOTTLE (43598-572-11) Famotidine DR. REDDY'S LABORATORIES INC 2024-03-15
51407-0452-50 50 mL in 1 BOTTLE (51407-452-50) Famotidine Golden State Medical Supply, Inc. 2021-05-19
59651-0701-50 50 mL in 1 BOTTLE (59651-701-50) FAMOTIDINE Aurobindo Pharma Limited 2025-07-09
60219-2090-04 50 mL in 1 BOTTLE (60219-2090-4) Famotidine Amneal Pharmaceuticals NY LLC 2024-05-13
67877-0775-89 50 mL in 1 BOTTLE (67877-775-89) Famotidine Ascend Laboratories, LLC 2023-08-24
68180-0150-01 50 mL in 1 BOTTLE (68180-150-01) Famotidine Lupin Pharmaceuticals, Inc. 2010-06-29
68382-0444-05 50 mL in 1 BOTTLE, PLASTIC (68382-444-05) FAMOTIDINE Zydus Pharmaceuticals USA Inc. 2021-04-22
68475-0400-01 50 mL in 1 BOTTLE, PLASTIC (68475-400-01) famotidine Navinta LLC 2021-04-22
69238-2090-04 50 mL in 1 BOTTLE (69238-2090-4) Famotidine Amneal Pharmaceuticals NY LLC 2022-08-05
70377-0113-11 50 mL in 1 BOTTLE (70377-113-11) FAMOTIDINE Biocon Pharma Inc. 2023-09-01
70954-0316-10 50 mL in 1 BOTTLE (70954-316-10) Famotidine ANI Pharmaceuticals, Inc. 2021-04-20
72162-2599-02 50 mL in 1 BOTTLE (72162-2599-2) FAMOTIDINE Bryant Ranch Prepack 2026-01-09
72205-0233-84 55 mL in 1 BOTTLE (72205-233-84) FAMOTIDINE Novadoz Pharmaceuticals LLC 2025-08-16
72603-0171-01 50 mL in 1 BOTTLE (72603-171-01) Famotidine NorthStar Rx LLC 2023-09-07
80005-0119-16 50 mL in 1 BOTTLE (80005-119-16) FAMOTIDINE Carnegie Pharmaceuticals LLC 2023-08-10
Observed labelers: Upsher-Smith Laboratories, LLC (3) · Amneal Pharmaceuticals NY LLC (2) · Ajanta Pharma USA Inc. (1) · ANI Pharmaceuticals, Inc. (1) · Ascend Laboratories, LLC (1) · Aurobindo Pharma Limited (1) · +14 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.